| Table 4. Comparison of main methods available in Brazil to detect COVID-19. | ||||
| Technology | RT-PCR | ELISA | CLIA | Immunochromatography |
|---|---|---|---|---|
| Molecule tested | Viral RNA | Antibodies -IgA/IgM and IgG |
Antibodies -IgA/IgM and IgG |
Antibodies -IgM and IgG Few detect viral antigens |
| Type of sample required | Nasopharyngeal swabs or other upper respiratory tract specimens | Serum or plasma | Serum or plasma | Blood, plasma or Serum |
| Laboratory or point of care | Laboratory based | Laboratory based | Laboratory based | Point of care |
| Time to results | 3-4 hours | 1-5 hours | 1-5 hours | 15-30 minutes |
| Advantages | Gold Standard Multiple samples at once Acute phase detection |
Multiple samples at once Identification of previous infection |
Multiple samples at once Identification of previous infection |
Fast |
| Disadvantages | Needs trained personnel Assays are easy to contaminate Difficult collection of sample |
Needs trained personnel Detection limit for asymptomatic individuals |
Needs trained personnel Detection limit for asymptomatic individuals |
High rate of false negative |